These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38151056)

  • 1. Hyperconcentrated glabellar injections to mitigate risk of botulinum toxin A-induced blepharoptosis: An unnecessary precaution.
    Labadie JG; Dover JS
    J Am Acad Dermatol; 2024 Jun; 90(6):1311-1312. PubMed ID: 38151056
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitigation of risk of botulinum toxin A-induced blepharoptosis with hyperconcentrated glabellar injections.
    Ghanian S; Wambier SPF; Wambier CG
    J Am Acad Dermatol; 2024 Jun; 90(6):1309-1310. PubMed ID: 38151057
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
    Nestor MS; Han H; Gade A; Fischer D; Saban Y; Polselli R
    J Cosmet Dermatol; 2021 Oct; 20(10):3133-3146. PubMed ID: 34378298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DaxibotulinumtoxinA (Daxxify) for frown lines.
    Med Lett Drugs Ther; 2024 Jul; 66(1707):e121-e122. PubMed ID: 39008109
    [No Abstract]   [Full Text] [Related]  

  • 5. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
    Reddy UP; Woodward JA
    Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery.
    Shome D; Jain V; Natarajan S
    Indian J Ophthalmol; 2007; 55(4):307-8. PubMed ID: 17595485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
    Bernardini FP; Skippen B; Croasdell B; Cerón Bohórquez JM; Murray G; Sayed K; Walker L; Hartstein ME;
    Aesthet Surg J; 2023 Aug; 43(9):955-961. PubMed ID: 36943792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies.
    Beer KR; Shamban AT; Avelar RL; Gross JE; Jonker A
    Dermatol Surg; 2019 Nov; 45(11):1381-1393. PubMed ID: 30893162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
    Ellis MF; Daniell M
    Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies.
    Cavallini M; Cirillo P; Fundarò SP; Quartucci S; Sciuto C; Sito G; Tonini D; Trocchi G; Signorini M
    Dermatol Surg; 2014 May; 40(5):525-36. PubMed ID: 24575858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin injection for production of ptosis].
    Merté RL; Lanzl IM
    Ophthalmologe; 2007 Sep; 104(9):767-70. PubMed ID: 17846779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inferior Oblique Palsy After Cosmetic Botox Injection for Glabellar Lines: A Case Report.
    Pucchio AA; Quinn MP
    J Neuroophthalmol; 2024 Sep; 44(3):e427-e428. PubMed ID: 36857138
    [No Abstract]   [Full Text] [Related]  

  • 14. Botox for rejuvenation of the periorbital region.
    Frankel AS
    Facial Plast Surg; 1999; 15(3):255-62. PubMed ID: 11816088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation.
    Aristodemou P; Watt L; Baldwin C; Hugkulstone C
    Ophthalmic Plast Reconstr Surg; 2006; 22(2):134-6. PubMed ID: 16550061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bidirectional Movement of the Frontalis Muscle: Introducing the Line of Convergence and Its Potential Clinical Relevance.
    Cotofana S; Freytag DL; Frank K; Sattler S; Landau M; Pavicic T; Fabi S; Lachman N; Hernandez CA; Green JB
    Plast Reconstr Surg; 2020 May; 145(5):1155-1162. PubMed ID: 32332530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Duration of Effect of 40-Unit PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multicenter, Randomized, Double-Blind, Active-Controlled Trial.
    Fagien S; Avelar RL; Cox SE; Joseph JH; Kaufman-Janette J; Marcus KA
    Aesthet Surg J; 2024 Aug; 44(9):987-1000. PubMed ID: 38506148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Increasing the Dose of Abobotulinumtoxina Impact the Duration of Effectiveness for the Treatment of Moderate to Severe Glabellar Lines?
    Joseph JH; Eaton LL; Robinson J; Pontius A; Williams EF
    J Drugs Dermatol; 2016 Dec; 15(12):1544-1549. PubMed ID: 29106437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
    Lorenc ZP; Smith S; Nestor M; Nelson D; Moradi A
    Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.